Cargando…

Targeting Adenosine Signaling in Parkinson's Disease: From Pharmacological to Non-pharmacological Approaches

Parkinson's disease (PD) is one of the most prevalent neurodegenerative disease displaying negative impacts on both the health and social ability of patients and considerable economical costs. The classical anti-parkinsonian drugs based in dopaminergic replacement are the standard treatment, bu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nazario, Luiza R., da Silva, Rosane S., Bonan, Carla D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703841/ https://www.ncbi.nlm.nih.gov/pubmed/29217998 http://dx.doi.org/10.3389/fnins.2017.00658

Ejemplares similares

Management of dysphagia and gastroparesis in Parkinson’s disease in real-world clinical practice – Balancing pharmacological and non-pharmacological approaches
por: Bhidayasiri, Roongroj, et al.
Publicado: (2022)

Rational Pharmacological Approaches for Cognitive Dysfunction and Depression in Parkinson’s Disease
por: Sandoval-Rincón, Maritza, et al.
Publicado: (2015)

A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions
por: Bonito-Oliva, Alessandra, et al.
Publicado: (2014)

Pharmacological and Non-pharmacological Treatments of Sleep Disorders in Parkinson's Disease
por: Taximaimaiti, Reyisha, et al.
Publicado: (2021)

Pharmacological Targeting of Microglial Activation: New Therapeutic Approach
por: Liu, Cai-Yun, et al.
Publicado: (2019)

Pharmacological and Non-Pharmacological Recanalization Strategies in Acute Ischemic Stroke
por: Frendl, Anita, et al.
Publicado: (2011)

The Pharmacological Potential of Adenosine A(2A) Receptor Antagonists for Treating Parkinson’s Disease
por: Mori, Akihisa, et al.
Publicado: (2022)

Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson’s Disease: An Updated Review
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

Emerging preclinical pharmacological targets for Parkinson's disease
por: More, Sandeep Vasant, et al.
Publicado: (2016)

Effects of non-pharmacological or pharmacological interventions on cognition and brain plasticity of aging individuals
por: Pieramico, Valentina, et al.
Publicado: (2014)

Pharmacological and non-pharmacological countermeasures to Space Motion Sickness: a systematic review
por: Khalid, Akil, et al.
Publicado: (2023)

Pharmacology of Adenosine Receptors: Recent Advancements
por: Vincenzi, Fabrizio, et al.
Publicado: (2023)

Pharmacological Interventions for REM Sleep Behavior Disorder in Parkinson's Disease: A Systematic Review
por: Yan, Junqiang, et al.
Publicado: (2021)

Studying Huntington’s Disease in Yeast: From Mechanisms to Pharmacological Approaches
por: Hofer, Sebastian, et al.
Publicado: (2018)

Non-Pharmacological Intervention for Memory Decline
por: Cotelli, Maria, et al.
Publicado: (2012)

Pharmacological validation of TDO as a target for Parkinson’s disease
por: Perez‐Pardo, Paula, et al.
Publicado: (2021)

Editorial: Zebrafish as a model for pharmacological and toxicological research
por: Bonan, Carla Denise, et al.
Publicado: (2022)

Pharmacological treatment of Parkinson’s disease
por: Arabia, G
Publicado: (2010)

Efficacy of non-pharmacological interventions for depression in individuals with Parkinson's disease: A systematic review and network meta-analysis
por: Wang, Yuxin, et al.
Publicado: (2022)

Capping and adenosine metabolism. Genetic and pharmacologic studies
Publicado: (1980)

Electrocardiographic profile of adenosine pharmacological stress testing
por: SUN, HAO, et al.
Publicado: (2015)

Purinergic Signaling in the Pathophysiology and Treatment of Huntington’s Disease
por: Wiprich, Melissa Talita, et al.
Publicado: (2021)

Targeting the autophagy-lysosomal pathway in Huntington disease: a pharmacological perspective
por: Yang, Junsheng, et al.
Publicado: (2023)

Overview of Meta-Analyses of Five Non-pharmacological Interventions for Alzheimer's Disease
por: Wang, Liao-Yao, et al.
Publicado: (2020)

Neuroprotective Potential and Underlying Pharmacological Mechanism of Carvacrol for Alzheimer’s and Parkinson’s Diseases
por: Javed, Hayate, et al.
Publicado: (2023)

Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic Pain
por: Vincenzi, Fabrizio, et al.
Publicado: (2020)

Managing Obesity and Related Comorbidities: A Potential Pharmacological Target in the Adenosine System?
por: D’Antongiovanni, Vanessa, et al.
Publicado: (2021)

Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage
por: Marinelli, Carla, et al.
Publicado: (2016)

Corrigendum: Advances in non-dopaminergic pharmacological treatments of Parkinson's disease
por: Stayte, Sandy, et al.
Publicado: (2014)

Mechanisms involved in adenosine pharmacological preconditioning-induced cardioprotection
por: Singh, Lovedeep, et al.
Publicado: (2018)

The Signaling and Pharmacology of the Dopamine D1 Receptor
por: Jones-Tabah, Jace, et al.
Publicado: (2022)

Pharmacological Preconditioning with GYKI 52466: A Prophylactic Approach to Neuroprotection
por: Goulton, Chelsea S., et al.
Publicado: (2010)

Exploring the Pharmacological Potential of Metformin for Neurodegenerative Diseases
por: Du, Ming-Rui, et al.
Publicado: (2022)

Adenosine A(1)-A(2A) Receptor Heteromer as a Possible Target for Early-Onset Parkinson's Disease
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2017)

Network pharmacology identify intersection genes of quercetin and Alzheimer’s disease as potential therapeutic targets
por: Wei, Caihui, et al.
Publicado: (2022)

Treatment of the later stages of Parkinson’s disease – pharmacological approaches now and in the future
por: Jenner, Peter
Publicado: (2015)

Pharmacological Tuning of Adenosine Signal Nuances Underlying Heart Failure With Preserved Ejection Fraction
por: Campos-Martins, Alexandrina, et al.
Publicado: (2021)

Interactions of the microbiome with pharmacological and non-pharmacological approaches for the management of ageing-related musculoskeletal diseases
por: Papageorgiou, Maria, et al.
Publicado: (2021)

Cognitive Intervention As an Early Non-pharmacological Strategy in Alzheimer's Disease: A Translational Perspective
por: Gehres, Sarah W., et al.
Publicado: (2016)

Non-Pharmacological Approaches for Migraine
por: Puledda, Francesca, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hmj3dhf4s5vdsgohr6icag01ib